(Q78766951)
English
Phase III randomized study comparing 5 or 10 microg per kg per day of filgrastim for mobilization of peripheral blood progenitor cells with chemotherapy, followed by intensification and autologous transplantation in patients with nonmyeloid malignan
scientific article published on 01 January 2003
Statements
Phase III randomized study comparing 5 or 10 microg per kg per day of filgrastim for mobilization of peripheral blood progenitor cells with chemotherapy, followed by intensification and autologous transplantation in patients with nonmyeloid malignancies (English)
Marc André
Etienne Baudoux
Dominique Bron
Jean-Luc Canon
Véronique D'Hondt
Marie-France Fassotte
Lionel D'Hondt
Georges Fillet
Yves Humblet
Guy Jerusalem
Philippe Vermeulen
Michel Symann
Yves Beguin
1 January 2003
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference